Swapna Hair Enricher is my major invention of 1991. It can control Hairloss and Dandruff simultaneously within 4 weeks in nearly almost all normal cases, with both genders. I am a haircare researcher since 1991.

My basic qualification is M.Sc in Organic Chemistry. After that, I have done the commonly called MBA course from Indian Institute of Management, Ahmedabad in 1969.

Now I am in my 69th year. I am not keen on manufacturing and marketing products at this stage. I wish to sell or share the Technology of different formulations in a suitable way. From the links given above, one can refer to other pages and products

 

The Product

 

Swapna simultaneously controls hairloss and dandruff within 4 weeks in almost all normal cases, with both genders. The site proves this point with demonstrated results

Allopathy does not provide any easy and simple solution for either hairloss control or dandruff. Swapna scores over 2 FDA approved hair gain products in several basic features

 There is no other equivalent product in the World to the best of my knowledge and belief.

 

Value of Swapna to the Society

 

It can save the available hair, if not anything else. That in itself, is great. It is a proven hair saver plus, for nearly all

The silent untold agony of a Billion can be doused.

Wasted expenses on Shampoos, Anti Dandruff Shampoos and hairloss control lotions can be reduced / avoided

May trigger meaningful functional research for the future, replacing many present meaningless excuses -

 

Price for the Technology

For Philanthropists

If Philanthropist/s / Social Welfare Organisations, singly or jointly, pay me a Million Dollar or two [net after tax] and make open the formulation of Swapna to the Public, it becomes free to the World.

Then, Millions in India and others outside can save the hair at near zero cost

And 60% of the sum mentioned above is intended for Charitable causes which is why, I thought that amount.

 

Commercial

 

The base price is double of the sum mentioned above. There would also be Royalty. Commercial Organisations can study the product and send their proposals for outright sales

 

Technical Licensing

Technical Licensing option is open for all products / Technologies. It is for the Prospective Buyers to send a suitable proposal. Some technology like the Invention has more value as I have not seen any equivalent in the last 20 years. I only have a broad outline but no definitive  terms about licensing.  I wish that there is a reasonable 'initial payment' befitting the perceived product strength / market potential. Such Licensing should be specific for a particular geographical area.  5% Royalty on Sales can go to some charity / my progeny / social causes. I still wish that I do get reasonable amount such that 60% can go to charitable causes.

For non exclusive offers:

Minimum 4 and Maximum 10 entities can get technical guidance to sell the product in India.  There has be an initial down payment - 5 lakhs. Technical Guidance will be given for the manufacture of the product. Secret concentrate, which can be minimum 10% and maximum 20% of the total formulation will have to be taken from me.

The agent has to manufacture and market the product on their own with a different brand name.  My future role will be limited to the supply of the concentrate as a commercial transaction - purchase of a product by a buyer from a seller

Note:

I did not think of the idea of commercial arrangement till recently. Naturally, I have not thought deeply about the terms. The above points needs further refinement at the right time.  The broad framework I have is that it should be mutually beneficial. It should benefit the Society a bit more. Those who wish to make huge profits in double quick time need not refer to me. Had that was not repugnant to me, I would have sold off Swapna by 1998.

Free samples are not provided as a matter of policy. Reasonable quantity of products / worth around, say Rs 5000, have to be bought initially for one's own assessment before taking the next call.

This page will get refined, modified and reedited depending upon the queries, points overlooked or unclear as of now - 4th Feb 2012

 

Contact details